Literature DB >> 22802345

A ferritin mutant of Mycobacterium tuberculosis is highly susceptible to killing by antibiotics and is unable to establish a chronic infection in mice.

Ruchi Pandey1, G Marcela Rodriguez.   

Abstract

Iron is an essential, elusive, and potentially toxic nutrient for most pathogens, including Mycobacterium tuberculosis. Due to the poor solubility of ferric iron under aerobic conditions, free iron is not found in the host. M. tuberculosis requires specialized iron acquisition systems to replicate and cause disease. It also depends on a strict control of iron metabolism and intracellular iron levels to prevent iron-mediated toxicity. Under conditions of iron sufficiency, M. tuberculosis represses iron acquisition and induces iron storage, suggesting an important role for iron storage proteins in iron homeostasis. M. tuberculosis synthesizes two iron storage proteins, a ferritin (BfrB) and a bacterioferritin (BfrA). The individual contributions of these proteins to the adaptive response of M. tuberculosis to changes in iron availability are not clear. By generating individual knockout strains of bfrA and bfrB, the contribution of each one of these proteins to the maintenance of iron homeostasis was determined. The effect of altered iron homeostasis, resulting from impaired iron storage, on the resistance of M. tuberculosis to in vitro and in vivo stresses was examined. The results show that ferritin is required to maintain iron homeostasis, whereas bacterioferritin seems to be dispensable for this function. M. tuberculosis lacking ferritin suffers from iron-mediated toxicity, is unable to persist in mice, and, most importantly, is highly susceptible to killing by antibiotics, showing that endogenous oxidative stress can enhance the antibiotic killing of this important pathogen. These results are relevant for the design of new therapeutic strategies against M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802345      PMCID: PMC3457556          DOI: 10.1128/IAI.00229-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates.

Authors:  T R Garbe; N S Hibler; V Deretic
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

2.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol.

Authors:  Muhammad Malik; Tao Lu; Xilin Zhao; Anubha Singh; Christopher M Hattan; John Domagala; Robert Kerns; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis.

Authors:  G Marcela Rodriguez; Issar Smith
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

Review 5.  The diagnosis and therapy of tuberculosis during the past 100 years.

Authors:  Denis A Mitchison
Journal:  Am J Respir Crit Care Med       Date:  2005-02-11       Impact factor: 21.405

Review 6.  Iron storage in bacteria.

Authors:  S C Andrews
Journal:  Adv Microb Physiol       Date:  1998       Impact factor: 3.517

Review 7.  Interdependence of mycobacterial iron regulation, oxidative-stress response and isoniazid resistance.

Authors:  O Dussurget; I Smith
Journal:  Trends Microbiol       Date:  1998-09       Impact factor: 17.079

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid.

Authors:  V Deretic; E Pagán-Ramos; Y Zhang; S Dhandayuthapani; L E Via
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

10.  Ferritin mutants of Escherichia coli are iron deficient and growth impaired, and fur mutants are iron deficient.

Authors:  H Abdul-Tehrani; A J Hudson; Y S Chang; A R Timms; C Hawkins; J M Williams; P M Harrison; J R Guest; S C Andrews
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

View more
  46 in total

1.  Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteins.

Authors:  Heidi Contreras; Matthew S Joens; Lisa M McMath; Vincent P Le; Michael V Tullius; Jaqueline M Kimmey; Neda Bionghi; Marcus A Horwitz; James A J Fitzpatrick; Celia W Goulding
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

2.  Concerted motions networking pores and distant ferroxidase centers enable bacterioferritin function and iron traffic.

Authors:  Huili Yao; Huan Rui; Ritesh Kumar; Kate Eshelman; Scott Lovell; Kevin P Battaile; Wonpil Im; Mario Rivera
Journal:  Biochemistry       Date:  2015-02-17       Impact factor: 3.162

3.  IdeR is required for iron homeostasis and virulence in Mycobacterium tuberculosis.

Authors:  Ruchi Pandey; G Marcela Rodriguez
Journal:  Mol Microbiol       Date:  2013-11-10       Impact factor: 3.501

4.  Elevated Total Iron-Binding Capacity Is Associated with an Increased Risk of Celiac Disease.

Authors:  Dorothea Letner; Joanna Peloquin; Jacquelyn Durand; Anna Rutherford; Vijay Yajnik; Hamed Khalili; John Garber
Journal:  Dig Dis Sci       Date:  2015-07-15       Impact factor: 3.199

Review 5.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 6.  Bacterial Proteasomes: Mechanistic and Functional Insights.

Authors:  Samuel H Becker; K Heran Darwin
Journal:  Microbiol Mol Biol Rev       Date:  2016-12-14       Impact factor: 11.056

Review 7.  Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake.

Authors:  Manjula Sritharan
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

Review 8.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 9.  Advances in encapsulin nanocompartment biology and engineering.

Authors:  Jesse A Jones; Tobias W Giessen
Journal:  Biotechnol Bioeng       Date:  2020-10-01       Impact factor: 4.530

Review 10.  Iron in infection and immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.